In February 2024, the FDA approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil and leucovorin for the ...

Utilizing tools such as spreadsheet trackers can make a big difference when organizing cancer-related medical bills and noting out-of-pocket maximums.

Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a ...

Sharon Manson's 45-year career in oncology nursing includes roles from bedside nurse to assistant vice president of oncology ...

Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.

Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite ...

The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic ...

From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the ...

Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain ...

A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on ...

A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated ...

Disorganization, Smith said, is a common theme when it comes to the challenges around coordinating cancer care for a loved ...